MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, PROF made $5,337K in revenue. -$8,058K in net income. Net profit margin of -150.98%.

Income Overview

Revenue
$5,337K
Net Income
-$8,058K
Net Profit Margin
-150.98%
EPS
$0.19
Unit: Thousand (K) dollars
Revenue Breakdown
    • Capital Equipment
    • Recurring Non Capital
Revenue Breakdown
    • CA
    • US
    • DE
Revenue Breakdown
    • Transferred At Point In Time
    • Transferred Over Time

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenue (note 12)
5,337 5,977 5,289 2,211
Cost of sales
1,505 1,986 1,358 593
Gross profit
3,832 3,991 3,931 1,618
Research and development
5,262 4,272 5,418 6,098
Selling, general and administrative
6,591 7,088 7,426 9,326
Total operating expenses
11,853 11,360 12,844 15,424
Operating loss
-8,021 -7,369 -8,913 -13,806
Net finance (income) expense
377 160 122 343
Net foreign exchange (gain) loss
616 -939 935 -2,168
Total other (income) expenses
993 -779 1,057 -1,825
Net loss before income taxes
-7,028 -8,148 -7,856 -15,631
Income tax expense
27 12 100 78
Deferred tax expense (recovery)
-2 14 21 -14
Total income tax expense
25 26 121 64
Net loss attributed to shareholders for the period
-7,053 -8,174 -7,977 -15,695
Foreign currency translation adjustment
-1,005 275 -808 2,713
Net loss and other comprehensive loss for the period
-8,058 -7,899 -8,785 -12,982
Basic EPS
0.19 -0.257 0.26 0.52
Diluted EPS
0.19 -0.257 0.26 0.52
Basic Average Shares
36,297,684 30,732,490 30,104,497 30,053,142
Diluted Average Shares
36,297,684 30,732,490 30,104,497 30,053,142
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss and othercomprehensive loss for the...-$8,058K (24.13%↑ Y/Y)CA$2,086K US$777K (210.80%↑ Y/Y)CA$1,485K US$839K (-35.11%↓ Y/Y)DE$150K Net loss attributedto shareholders...-$7,053K (34.23%↑ Y/Y)Foreign currencytranslation adjustment-$1,005K (-1075.73%↓ Y/Y)Net foreignexchange (gain) loss$616K (1521.05%↑ Y/Y)Net finance(income) expense$377K (-15.28%↓ Y/Y)Capital Equipment$2,863K (249.15%↑ Y/Y)Recurring Non Capital$2,474K (37.37%↑ Y/Y)Net loss beforeincome taxes-$7,028K (34.21%↑ Y/Y)Total income taxexpense$25K (-39.02%↓ Y/Y)Total other (income)expenses$993K (105.59%↑ Y/Y)Deferred tax expense(recovery)-$2K Revenue (note 12)$5,337K (103.62%↑ Y/Y)Operating loss-$8,021K (28.17%↑ Y/Y)Income tax expense$27K (-34.15%↓ Y/Y)Gross profit$3,832K (106.80%↑ Y/Y)Cost of sales$1,505K (95.96%↑ Y/Y)Total operatingexpenses$11,853K (-8.96%↓ Y/Y)Selling, general andadministrative$6,591K (-19.73%↓ Y/Y)Research and development$5,262K (9.44%↑ Y/Y)

Profound Medical Corp. (PROF)

Profound Medical Corp. (PROF)